Ning Xie
No. 283, Tongzipo Road
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Crop rotation-based phytoremediation of metal(loid)s in contaminated farmlands: integrative mechanisms, risk boundaries, and implementation strategies.
Journal: International journal of phytoremediation
Published: July 21, 2026
Machine learning and cox model-based prediction of CDK4/6 inhibitor outcomes in HR+/HER2 - metastatic breast cancer: a multicenter real-world study.
Journal: Breast cancer research and treatment
Published: March 15, 2026
From Etiology to Aesthetic Surgery: Mapping Knowledge Domains and Emerging Trends in Gynecomastia Research: 35-Year Bibliometric Analysis.
Journal: Aesthetic plastic surgery
Published: November 19, 2025
Dual-Physical-Field Nanocatalysis: Injectable Hydrogel Enables Piezo-Photothermal Synergy for Breast Cancer Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 09, 2025
Advances in catheter ablation for patients with atrial fibrillation and heart failure
Journal: Zhonghua nei ke za zhi
Published: September 04, 2025
Genotype-dependent fortification of rice nodes dictates cadmium fate in grains: A synergistic barrier forged from cell wall and amino acid chelation.
Journal: Journal of hazardous materials
Published: July 30, 2025
Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China.
Journal: Translational breast cancer research : a journal focusing on translational research in breast cancer
Published: June 28, 2025
Treatment beyond progression and rechallenge with pyrotinib in HER2-positive metastatic breast cancer and brain metastases: a multicenter real-world study.
Journal: Therapeutic advances in medical oncology
Published: May 16, 2025
Efficacy and safety of utidelone in pretreated patients with metastatic breast cancer in China: a multicenter, real-world study.
Journal: Therapeutic advances in medical oncology
Published: April 20, 2025
BEBT-209, a primary CDK4 selective inhibitor, for the treatment of HR+/HER2- advanced breast cancer (BECTOP1): a phase 1, multicentre, open-label study.
Journal: Breast (Edinburgh, Scotland)
Published: March 19, 2025
Pyrotinib versus pertuzumab with trastuzumab and taxane in HER2-positive metastatic breast cancer: a Chinese multicenter real-world study.
Journal: The oncologist
Published: February 22, 2025
A Systematic Review of Mechanisms, Incidence, and Management of Trastuzumab Deruxtecan Induced ILD/Pneumonitis in Solid Tumors.
Journal: Drug design, development and therapy
Published: November 26, 2024
Last Updated: 09/26/2026